Nvwm, LLC Guardant Health, Inc. Transaction History

Nvwm, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$88.71 - $120.43 $650,865 - $883,594	-7,337 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$98.77 - $132.17 $4,938 - $6,608	-50 Reduced 0.68%	7,337 $917,000
Q2 2021 Aug 04, 2021	BUY	$109.77 - $165.68 $2,854 - $4,307	26 Added 0.35%	7,387 $918,000
Q1 2021 May 11, 2021	SELL	$127.04 - $179.1 $18,420 - $25,969	-145 Reduced 1.93%	7,361 $1.12 Million
Q4 2020 Feb 09, 2021	BUY	$99.96 - $135.93 $22,091 - $30,040	221 Added 3.03%	7,506 $968,000
Q3 2020 Dec 10, 2020	BUY	$80.32 - $111.8 $883 - $1,229	11 Added 0.15%	7,285 $814,000
Q2 2020 Aug 11, 2020	BUY	$60.49 - $97.5 $22,804 - $36,757	377 Added 5.47%	7,274 $590,000
Q1 2020 May 08, 2020	BUY	$59.04 - $88.81 $34,951 - $52,575	592 Added 9.39%	6,897 $480,000
Q4 2019 Feb 07, 2020	BUY	$59.49 - $82.78 $375,084 - $521,927	6,305 New	6,305 $493,000

324

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.83B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Nvwm, LLC with notifications on news.